An engineered SARS-CoV-2 receptor-binding domain produced in Pichia pastoris as a candidate vaccine antigenMiladys Limonta‐Fernández, Gerardo Guillén, Ania Cabrales et al.|New Biotechnology|2022Cited by 58
The SARS-CoV-2 receptor-binding domain expressed in Pichia pastoris as a candidate vaccine antigenMiladys Limonta‐Fernández, Gerardo Guillén, Glay Chinea-Santiago et al.|medRxiv|2021Cited by 19
In-solution buffer-free digestion allows full-sequence coverage and complete characterization of post-translational modifications of the receptor-binding domain of SARS-CoV-2 in a single ESI–MS spectrumLuis Ariel Espinosa, Luis Javier González, Yassel Ramos et al.|Analytical and Bioanalytical Chemistry|2021Cited by 17
In-solution buffer-free digestion for the analysis of SARS-CoV-2 RBD proteins allows a full sequence coverage and detection of post-translational modifications in a single ESI-MS spectrumLuis Ariel Espinosa, Luis Javier González, Yassel Ramos et al.|bioRxiv (Cold Spring Harbor Laboratory)|2021Cited by 4